摘要 |
Compounds of formula (I) wherein R<SUB>1 </SUB>or R<SUB>2 </SUB>is an aromatic or non-aromatic ring directly joined or joined by a linker, as represented by L<SUB>2 </SUB>and L<SUB>3</SUB>, to a heteroaromatic core, and X, X', Y, Y', Z, Z', R<SUB>1</SUB>, R<SUB>2</SUB>, R<SUB>3</SUB>, R<SUB>3a</SUB>, R<SUB>3b</SUB>, R<SUB>4</SUB>, R<SUB>5</SUB>, L, L<SUB>2</SUB>, and L<SUB>3 </SUB>are as defined herein, are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands, methods for using such compounds and compositions, and a process for preparing compounds within the scope of formula (I).
|